Downregulation of GATS gene inhibits proliferation,clonogenicity and migration in triple negative breast cancer cells MDA-MB-231 by cell autophagy

Abstract

The triple negative breast cancer (TNBC) accounts for 15% to 20% of the total number of breast cancer diagnosed. A number of clinical studies have shown that TNBC has a high risk of early recurrence and distant metastasis, and a low rate of disease free survival and total survival. The premise of TNBC deterioration was abnormal proliferation and migration of tumor cells, and this study firstly showed that GATS gene could promote proliferation of MDA-MB-231 breast cancer cells. Through lentiviral expression system, the GATS gene was konckdown by shGATS lentivirus infection in the MDA-MB-231 cells, and the result indicated it could remarkably decrease the ability of cell proliferation and migration. Real-time PCR, western blot and immunofluorescence experiments showed the expressions of protein LC3, and p-Akt in shGATS cell group were lower than the shCtrl group. Therefore, we suggest the GATS could promote the MDA-MB-231 cell proliferation, migration and clonogenicity through cell autophagy by the PI3K/Akt pathway, which paved the way for further study the function of GATS in TNBC, and GATS may potentially be a target for gene therapy against triple negative breast cancer.

Keywords

Triple negative breast cancer cell proliferation autophagy PI3K/Akt signal pathway

1. Introduction

Breast cancer with high heterogeneity is one of the most common malignant tumors in women, which is the main cause of cancer death in women. According to statistics, the annual incidence of breast cancer is about 167.1 million population, and the death rate is about 52.2 million population [1]. In addition, the age of breast cancer is becoming younger, which has been attracted the worldwide attention [2]. Breast cancer could be divided into four different subtypes according to the expression levels of human epidermal growth factor receptor (HER2), estrogen receptor (ER) and progestin receptor (PR), such as Luminal A, Luminal B, HER2 ${}^{+}$ and the triple negative breast cancer (TNBC) [3]. For the first three subtypes of breast cancer, there are targeted drug research and development, which could effectively prolong the overall survival of metastatic breast cancer [4]. However, the TNBC is lack of effective targeted therapy for its high heterogeneity, and the prognosis of chemotherapy is worse than that of other types of breast cancer. TNBC is mostly invasive ductal carcinoma of high grade, which has highly invasive biological behavior, accounting for 15% to 20% of the total number of breast cancer diagnosed [5]. A number of clinical studies have shown that TNBC has a high risk of early recurrence and distant metastasis, and a low rate of disease free survival and total survival, which has been gradually become the difficult and hot spot in the field of breast cancer [6]. At present, the main treatment of TNBC is a chemotherapy regimen of taxol or platinum, but most patients have malignant transformation of the tumor for a year or so, and the benefit rate is at a lower level [7]. Therefore, elucidating the mechanism of TNBC malignant transformation, then screening effective target proteins and conducting effective intervention will help to develop the target drug of TNBC and improve the medicine clinical value.

Autophagy has become a research hotspot in the regulation of malignant phenotype of tumor cells [8]. The study shows that autophagy can promote the expression of tumor proliferation related genes and lead to the high invasion and metastasis of tumor [9]. Autophagy is considered to impede the occurrence of tumor during the early stage of tumor development, but autophagy after radiotherapy and chemotherapy can remove and utilize the harmful substances inside and outside the cell in time to promote the deterioration and metastasis of the tumor. This may be the main cause of the refractory treatment of cancer patients in clinical cancer [10], so several scholars have suggested that inhibiting autophagy can improve the chemosensitivity of breast cancer cells [11]. For the subtypes of breast cancer Luminal A, Luminal B and HER2 ${}^{+}$ , there are clinical studies have shown that the combination of targeted drugs and autophagy inhibitors can improve the therapeutic effect [12, 13]. Therefore, it is necessary to screen the key regulatory genes for the malignant transformation of TNBC, and to study the key pathway of autophagy in TNBC, so as to improve the chemotherapeutic effect of malignant triple negative breast cancer by inhibiting autophagy.

The gene encoding human GATS protein is a single copy gene located on the 22 arm of chromosome 7 (7q22.1), consisting of 9 exons, containing 163 amino acids. The GenBank accession number of GATS is NM_178831, and its database analysis showed that the molecular weight of GATS protein was 17.8 kDa and the isoelectric point was 8.78. Transcriptional sequence and proteomics studies show that the GATS gene is expressed in all tissues of the human body, especially in the brain, testis, ovary and endometrium [14], but until now there is no specific report about the function of GATS gene. Therefore, in this study we firstly found the downexpression of GATS could decrease the cell autophagy in MDA-MB-231 cells by the the PI3K/Akt signal transduction pathway. And the molecular experiments showed that GATS could promote the proliferation and metastasis of MDA-MB-231 cells, this may provide an effective method for developing targeted drug to treat TNBC.

2. Materials and methods

2.1 Cell lines and cell culture

Human breast cancer cell lines MDA-MB-231, MCF-7, T47D, 293T were maintained in our laboratory. Cell lines were cultured in RPMI 1640 (Gibco, USA) supplemented with 10% fetal calf serum (Gibco), and 1% penicillin and streptomycin (Invitrogen, USA) at 37 ${}^{\circ}$ C in a humidified atmosphere with 5% CO ${}_{2}$ .

2.2 qRT-PCR analysis of mRNA expression

The RT-PCR primer sequences used for GATS were as follows: F: 5’-TATTGGCATG ACCAAGATCG-3’; R: 5’-TTGAGCACCAGGATGAAGTCT-3’, and the relative amount of each mRNA was normalized to GAPDH, which was amplified by the primers: F: 5’-TGACTTCAACAGCGACACCCA-3’; R: 5’-CACCC TGTTGCTGT AGCCAAA-3’. Total RNA was isolated with TRIzol reagent (Invitrogen) according to the manufacturer’s protocol, then the cDNA was synthesized by the RevertAid First-Strand cDNA Synthesis Kit (Fermentas, USA). The expression levels of each analyte compared with untreated controls was assessed using the 2 ${}^{-\Delta\Delta\text{Ct}}$ method, where $\Delta\Delta$ Ct $=$ (Ct ${}_{\text{miRNA}}$ $-$ Ct ${}_{\text{internal reference}})_{\text{experiment}}$ $-$ (Ct ${}_{\text{miRNA}}$ $-$ Ct ${}_{\text{internal reference}})_{\text{control}}$ [15].

2.3 ShRNA design of GATS and its lentivirus construction

The shRNA interference sequence of GATS was designed according to the selected target sequence as 5’-CACCAGAGGATTACACTAT-3’, and the restriction sites Age I and EcoR I were added at both ends to complete the construcion of the lentivirus vector GV115-GATS-shRNA (Genechem Co., Ltd., Shanghai, China). The recombinant plasmid was tranfected into the prepared Escherichia coli receptive cell, and the positive clone was selected by the PCR method. Then the extracted plasmid was sent to sequencing to verify there was no mutation in the shRNA sequence.

The logarithmic growth phase 293T cells were inoculated in 10 cm cell culture dishes, and adjusted the cell density to about 70%–80%. Then the vectors 20 $\mu$ g GV115-GATS-shRNA, 15 $\mu$ g pHelper 1.0 and 10 $\mu$ g pHelper 2.0 were cotransfeccted into the 293T cells. After 48 h culture, the 293T cell supernatant was obtained by centrifuge at 4000 g for 10 mins, and filtrate the supernatant in a 40 ml ultracentrifuge tube with a 0.45 $\mu$ m filter, then put the tube into the Beckman ultrafast centrifuge about 25000 rpm for 2 h. After the end of the centrifuge, get rid of the supernatant and try to remove the liquid that remains on the wall of the tube, and added the virus preservation solution (instead of the PBS cell culture medium) and gently and repeatedly blow the precipitate into a suspension, the lentivirus named shGATS, and the control lentivirus named as the shCtrl [16].

2.4 Cell proliferation assay

The Cell Counting Kit 8 (CCK-8) was conducted as follows: briefly, 1,000 cells of each group were plated per well in 96-well microplates in 150 $\mu$ l of medium with different concentration chemotherapy drug. After 48 h of culture, 10 $\mu$ l CCK-8 solution was added to the medium, and the cells were incubated for 3 h at 37 ${}^{\circ}$ C. The optical density at 570 nm was measured with a microplate spectrophotometer. Three independent experiments were performed, and the 50% inhibting concentration (IC50) derived from the curve fitting method.

For the proliferation assay of cells with green fluorescence were calculated by the Celigo machine (Nexcelom Bioscience LLC., MA, USA). By adjusting the input parameters of analysis settings, the data and the cell proliferation curve were plotted for 5 days.

2.5 Clonogenicity assay

The cancer cells were transfected with GATS- shRNA or control RNA for 12 h, and then transferred to six-well plates and seeded at a density of 1.0 $\times$ 10 ${}^{3}$ cells per well. The plates were incubated at 37 ${}^{\circ}$ C in a humidified atmosphere of 5% CO ${}_{2}$ for 12 days. The culture medium was changed every three days. Clonogenicity was analyzed at 12 days following the shRNA transfection. The plates were stained with 0.05% crystal violet solution for 15 min, and the colonies were counted under the inverted microscope and photographed. The experiments were performed in triplicate, at minimum. Data are presented as the mean $\pm$ standard.

2.6 Scratch-healing assay

MDA-MB-231 cells were seeded into six-well plates at a density of 0.8 $\times$ 10 ${}^{5}$ cells per well. Following overnight incubation, the cells were transfected with 50 nmol/l shRNA – GATS or control RNA for 72 h until the cells reached full confluence. A monolayer of cells was scratched by a 1-mm micropipette tip, rinsed with PBS to remove cell debris and cultured continuously in growth medium containing 1% fetal bovine serum (Gibco-BRL, Invitrogen Life Technologies). The wound-closing procedure was observed for 24 h. The wound width of each well was calculated at 24 h interval.

2.7 Cell cycle detection by FCM (flow cytometry)

The cells (1 $\times$ 10 ${}^{6}$ cells/ml) were transfected with shRNA or control RNA. At 96 h following transfection, the cells were harvested and fixed in 70% ethanol at $-$ 20 ${}^{\circ}$ C overnight, and then stained with 250 $\mu$ g/ml propidium iodide (Sigma-Aldrich), 5 $\mu$ g/ml RNase A (Sigma-Aldrich) and 5 mmol/l EDTA in PBS (pH 7.4) for 30 min. The cell cycle analysis was performed using the FACScan (Beckman Instruments, Fullerton, CA, USA). The data was evaluated using the FlowJo software (Tree Star, Inc. Ashland, OR, USA).

2.8 Immunofluorescence

The cells were seeded in a 6-well plates after digestion, then fixed in 4% paraformaldehyde, permeabilized, blocked with 3% BSA, and incubated with LC3 antibody (Santa Cruz, CA, USA) for 1 h at 37 ${}^{\circ}$ C. The cells were then washed and incubated with the secondary antibody for 1 h at room temperature. After washed with PBS, the cells incubated with DAPI for 5 min. After dyed, the cells were washed 4 times with PBST to wash away the excess DAPI, and immunofluorescence images were acquired.

Figure 1.

High expression of GATS in triple negative breast cancer cells MDA-MB-231. A, RT-PCR analysis of GATS expression in breast cancer cell lines MDA-MB-231, MCF-7 and T47D; B, the protein expression levels of GATS in breast cancer cell lines MDA-MB-231, MCF-7 and T47D. Data are shown as means $\pm$ SD, and ${}^{**}$ represents $p<$ 0.05.

Figure 2.

Downexpression of GATS inhibited colony formation of MDA-MB-231 cells. A, the number of colonies in shGATS group were much less than those in the control group, and figures of soft agar cloned experimental plate were obtained by digital camera, ${}^{***}$ represents $p<$ 0.001; B, the size of colony in shGATS group was smaller than those in shCtrl group. The figures of upper row obtained under the white field, and the figures of lower row obtained under the fluorescence field. The magnification of the microscope is 100 $\times$ .

Figure 3.

Downexpression of GATS inhibited proliferation and migration of MDA-MB-231 cells. A, proliferation curve of MDA-MB-231 cells in shCtrl and shGATS group under the fluorescence field; B, wound closure assay revealed a clear inhibiting effect on cell migration by observation at 24 h in shGATS group (magnification, $\times$ 40). The wound widths of MDA-MB-231 migration at 24 h were compared between the shGATS group, and the shCtrl group cells (284.66 vs.485.00 $\mu$ m), ${}^{***}$ represents $p<$ 0.001.

Figure 4.

Effect of GATS downexpression on the MDA-MB-231 cell cycle. shGATS infection MDA-MB-231 cells showed an increased percentage of G0/G1 phase cells and a decreased percentage of S phase cells. ${}^{**}$ represents $p<$ 0.05.

Figure 5.

Downexpression of GATS inhibited the level of autophagy in MDA-MB-231 cells after 6 h starvation. A, the immunofluorescence images of MDA-MB-231 cells. The puncta were visualized by fluorescence microscope imaging of cells immunostained for nucleus and LC3 using DAPI (blue) and Alexa Fluor 488 secondary antibody conjugates (green), respectively. Arrow indicates the LC3 puncta, and the histogram indicated the relative average fluorescence density of each group cells, ${}^{**}$ represents $p<$ 0.05; B, the expression level of LC3, Akt and p-Akt in the MDA-MB-231 cells were measured by western blot, and the result showed that the GATS gene obviously decreased the expression level of LC3 and p-Akt protein.

2.9 Western blot analysis

Total cellular extracts were prepared by homogenization of 3 $\times$ 10 ${}^{6}$ to 5 $\times$ 10 ${}^{6}$ cells in radioimmunoprecipitation assay buffer (Beyotime, China). Western blot analysis was performed as described previously [20]. After 15% SDS-PAGE, the gel was immersed in cold transfer buffer (0.025 M Tris, 0.19 M glycine, 20% methanol), and the proteins were transferred to a PVDF membrane. The membrane was subsequently blocked in 3% skimmed milk powder in PBS Tween-20 (PBST) overnight at 4 ${}^{\circ}$ C and immunoblotted with the primary antibody (GATS antibody, Santa Cruz, USA; PI3K/Akt antibody, Sigma-Aldrich, USA) diluted 1:2000 for 1.5 h at room temperature. After washing 5 times with PBST, the membrane was incubated with peroxidase-conjugated goat anti-rabbit IgG (Sigma-Aldrich, St. Louis, MO, USA) diluted 1:5000 for 1.5 h at room temperature. After washing with PBS for 5 times, the bands were visualized using DAB or the enhanced chemoluminescence (ECL) method (Thermo, Shanghai, China).

2.10 Statistical analysis

Data was shown as mean $\pm$ standard deviation. Statistical significance between groups was evaluated using Student’s $t$ test by SPSS PASW Statistics version 18 Multilingual (SPSS Inc., USA). A $p$ -value of less than 0.05 was considered statistically significant.

3. Results

3.1 GATS was highly expressed in the triple negative breast cancer cells MDA-MB-231

To investigate the expression level of GATS in TNBC cells, the real-time PCR of GATS was conducted in MDA-MB-231 cells. Compared with the other cell lines, the GATS mRNA level was obviously upregulated (Fig. 1A). The protein analysis by western blotting revealed that GATS protein was in accordance with the RT-PCR result, it was upregulated about 2-fold compared with the other control cells (Fig. 1B). Therefore, GATS was confirmed that it was highly expressed in the triple negative breast cells MDA-MB-231.

3.2 Downregulation of GATS inhibits colony formation of MDA-MB-231 cells

For analyzing the reason that GATS gene was highly expressed in TNBC cells, 5 $\mu$ l shCtrl (4 $\times$ 10 ${}^{8}$ TU/mL) and 3.3 $\mu$ l shGATS (6 $\times$ 10 ${}^{8}$ TU/mL) lentivirus infected into MDA-MB-231 cell lines for 12 h, respectively. The clonogenicty was analyzed at 7 days following the lentivirus infection. The number of colonies was significantly reduced in the shGATS group in MDA-MB-231 cells (31.0 vs 262.7 and 252.3; the mock and control groups, respectively, $p<$ 0.001), compared with the control groups (Fig. 2A), and the size of the colonies formed in shGATS group was smaller than that in the control groups (Fig. 2B).

3.3 Downregulation of GATS inhibits cell proliferation and migration of MDA-MB-231

For further study the functon of GATS gene, the lentivirus 5 $\mu$ l shCtrl (4 $\times$ 10 ${}^{8}$ TU/mL) and 3.3 $\mu$ l shGATS (6 $\times$ 10 ${}^{8}$ TU/mL) with the GFP element were infected into the MDA-MB-231 cells, respectively. According to the introduction of Celigo instrument, the cell proliferation of each day was detected by the GFP fluorescence. As shown in Fig. 3A, the downregulation of GATS gene obviously inhibited the cell proliferation of MDA-MB-231.

Next, the cell migration ability was analyzed using a wound closure experiment in MDA-MB-231 cells following shGATS lentivirus infection. The wound-closing procedure was serially observed for 72 h following the introduction of the wound on the plate. As shown in Fig. 3B, the speed of wound-closing was slower in shGATS-infected cells, compared with that in the control groups (uninfected and mock-infected GATS cells). This indicated that the downregulation of GATS expression inhibited cell migration in vitro.

3.4 Downregulation of GATS induces cell cycle arrest in MDA-MB-231 cells

The cell cycle fraction was investigated using flow cytometry based on shGATS infection for 96 h for TNBC cell lines. In the MDA-MB-231 cells, shGATS infection caused a significant increase in the G0/G1 fraction (56.23 vs. 51.98 and 51.95%; the mock and control groups, respectively) with concurrent decline in S (29.14 vs. 36.02 and 33.80%) and G2/M fractions (14.62 vs. 12.00 and 14.26%; the mock and control groups, respectively), compared with the controls (Fig. 4). Overall, these results indicated that the downregulation of the GATS gene by shGATS lentivirus induces G0/G1 phase arrest.

3.5 GATS regulates cell autophagy in MDA-MB-231 cells by the PI3K/Akt signaling pathway

To verify the relationship between GATS expression with cell autophagy, immunofluorescence expriment was conducted to detect the level of autophagy after the MDA-MB-231 cells infected with shGATS lentivirus. As shown in Fig. 5A, the level of autophagy in shGATS group was obviously decreased compared with the NC group after starvation for 6 hours, suggesting GATS could regulate cell autophagy in TNBC cells.

Next, to explore the cell autophagy mechanism of breast cancer cell regulated by GATS, the Akt signal pathway was confirmed to participate in autophage by western blotting experiment (Fig. 5B), and this indicated that GATS regulate cell autophagy through the Akt signal pathway.

4. Discussion

The triple negative breast cancer accounts for about 20% of the breast cancer, and the treatment of non-targeted drugs is easy to appear the malignant transformation of the tumor [17]. Therefore, it is necessary to screen the effective target for the deterioration and development of breast cancer. The premise of breast cancer deterioration is abnormal proliferation and migration of tumor cells [18]. In this study, GATS gene was firstly proved that it could promote proliferation, clonogenicity and migration of triple negative breast cancer cells MDA-MB-231. The structure and functional domain of bioinformatics showed that the 86-152 amino acid region of GATS was the aspartate kinase-chorismate mutase-tyrA (ACT) domain, which played an important role in the process of metabolic control, solute transport and signal transduction. At present, the studies about proteins containing the ACT domain were concentrated in the secondary metabolites of bacteria and plants, and many research results suggested that the encoded protein containing the ACT domain could promote the survival of the cells in the adversity environment [19, 20], which was similar to the malignant transformation of tumor cells under the action of chemotherapeutic drugs. The protein interaction prediction analysis showed that the interaction protein of GATS was nephronophthisis 3 (NPHP3). It was found that NPHP3 was closely related to the development of prostate cancer and the poor prognosis in the whole genome association of the tumor [21]. All these results indicated that GATS played an important role in the transformation of human tumor, and we firstly showed the GATS gene could promote the cell proliferation and migration.

The role of autophagy in regulating malignant transformation and chemoresistance is a hot topic in recent years. A large number of studies have shown that autophagy is considered to impede the occurrence of tumor during the early stage of tumor development, but autophagy could increase cancer cell proliferation and migration in time to promote the deterioration and metastasis of tumor after radiotherapy and chemotherapy, which may be the main failure reason for the treatment of cancer patients [22, 23]. Inhibition of autophagy is proposed to enhance chemosensitivity of breast cancer cells [24]. The study showed that the combination of rapamycin and resveratrol could effectively block autophagy and induce apoptosis in ER ${}^{+}$ breast cancer cells. At the same time, the inhibition of autophagy could benefit those patients with ER ${}^{+}$ breast cancer [25]. For HER2 ${}^{+}$ breast cancer patients, the haploid deletion of the autophagy key protein Beclin1 encoding gene BECN1 was often found, and HER2 targeting drug therapy would be more sensitive, suggesting that the combination of autophagy inhibitors and HER2 inhibitors would promote the therapeutic effect of breast cancer [26]. At present, there is a lack of research on autophagy inhibition in TNBC patients, and the main reason is no effective target of autophagy in TNBC. In this study, we firstly showed the GATS could regulate cell proliferation abnormality by the autophagy, this implied that the GATS gene maybe an effecitve target for therapy TNBC by inhibiting autophagy.

The study about the transformation of the TNBC malignant phenotype on the signal pathway is mainly focused on the PI3K/Akt signaling pathway, and the treatment of TNBC is also reported in many research practices, proving that the PI3K/Akt signaling pathway is closely related to the malignant proliferation of TNBC [27, 28]. Studies have found that hyaluronic acid, PI3K and epidermal growth factor receptor family can activate PI3K downstream molecules and mediate tumor cell proliferation [29]. And it is found that dietary inorganic sulfur can inhibit the expression of ErbB2 and ErbB3 through the Akt pathway, thereby reducing the proliferation of triple negative breast cancer cells [30]. The results are in agreement with the experimental results of GATS gene knockout expression, indirectly indicating that GATS molecules may induce the expression of ErbB2 regulated by PI3K/Akt pathway, thus stimulating the malignant proliferation of TNBC.

In conclusion, the GATS gene was proved highly expressed in the triple negative breast cancer cells. Using the lentivirus knockdown system, the effects of downregulating the GATS gene were explored in multiple biological features, including cell proliferation, migration, and the cell cycle. Further study showed the GATS gene regulated the cell proliferation by the cell autophagy through PI3K/Akt signal pathway. These findings provide evidence that GATS may potentially be a target for gene therapy against triple negative breast cancer. The downregulation of GATS may be a therapeutic strategy for the suppression of breast cancer progression, which provide an effective therapeutic method that could significantly improve the treatment of triple negative breast cancer.

Footnotes

Acknowledgments

This study was supported by the Provincial Natural Science Research Project of Anhui Colleges (KJ2017 ZD36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

References

Siegel

Naishadham

and Jemal

, CA: a cancer journal for clinicians, Cancer Statistics 62(1) (2012), 10–29.

Mello-Thoms

and Brennan

P.C.

, Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence, Breast Cancer Research and Treatment 159(3) (2016), 395–406.

Wen

Zhang

J.S.

Zhang

Y.J.

et al., Predictive value of molecular subtyping for locoregional recurrence in early-stage breast cancer with N1 without postmastectomy radiotherapy, Journal of Breast Cancer 19(2) (2016), 176–184.

Davis

N.M.

Sokolosky

Stadelman

et al., Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention, Oncotarget 5(13) (2014), 4603–4650.

Abramson

V.G.

and Mayer

I.A.

, Molecular heterogeneity of triple negative breast cancer, Current Breast Cancer Reports 6(3) (2014), 154–158.

Palma

Frasci

Chirico

et al., Triple negative breast cancer: looking for the missing link between biology and treatments, Oncotarget 6(29) (2015), 26560.

Mouh

F.Z.

Mzibri

M.E.

Slaoui

and Amrani

, Recent progress in triple negative breast cancer research, Asian Pac J Cancer Prev 17(4) (2016), 1595–1608.

Y.J.

Lei

Y.H.

Yao

Autophagy et al. and multidrug resistance in cancer, Chinese Journal of Cancer 36(1) (2017), 52.

Katheder

N.S.

Khezri

O’Farrell

et al., Microenvironmental autophagy promotes tumor growth, Nature 541(7637) (2017), 417–420.

10.

Panzarini

and Dini

, Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy? Molecular Pharmaceutics 11(8) (2014), 2527–2538.

11.

Wang

Sun

et al., Targeting autophagy augments the activity of DHA-E3 to over-come pgp mediated multidrug resistance, Biomedicine & Pharmacotherapy 84 (2016), 1610–1616.

12.

Alayev

Berger

S.M.

Kramer

M.Y.

et al., The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells, Journal of Cellular Biochemistry 116(3) (2015), 450–457.

13.

Zarzynska

J.M.

, The importance of autophagy regulation in breast cancer development and treatment, Biomed Research International (2014) (2014), 710345.

14.

Fagerberg

Hallström

B.M.

Oksvold

et al., Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-base dproteomics, Molecular & Cellular Proteomics 13(2) (2014), 397–406.

15.

Kovalchuk

Filkowski

Meservy

llnytskyy

Tryndyak

V.P.

Chekhun

V.F.

and Pogribny

I.P.

, Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin, Molecular Cancer Therapeutics 7(7) (2008), 2152–2159.

16.

Tang

Chen

J.X.

Chen

Tang

J.Y.

Cui

Liu

C.H.

and Wang

, Metastasis associated in colon cancer 1 (MACC1) promotes growth and metastasis processes of colon cancer cells, Eur Rev Med Pharmacol Sci 20(13) (2016), 2825–2834.

17.

Sarin

Khandrika

Hanitha

et al., Epidemiological and survival analysis of triple-negative breast cancer cases in a retrospective multicenter study, Indian J Cancer 53(3) (2016), 353–359.

18.

Kim

Gao

Sei

et al., Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing, Cell 74(18) (2018), 30365–30369. pii: S0092-86.

19.

Bitto

Kim

D.J.

, Bingman Crystal structure of tandem ACT domain-containing protein ACTP from Galdieria sulphuraria, Proteins 80(8) (2012), 2105–2109.

20.

Lien

E.C.

Ghisolfi

Geck

R.C.

et al., Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter Xct, Sci Signal 10(510) (2017), eaao6604.

21.

Ngollo

Lebert

Daures

et al., Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression, BMC Cancer 17(1) (2017), 261.

22.

Panzarini

and Dini

, Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy? Molecular Pharmaceutics 11(8) (2014), 2527–2538.

23.

Zhang

Chen

Zhou

et al., PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib, Cell Death Dis 9(3) (2018), 312.

24.

Wang

Sun

et al., Targeting autophagy augments the activity of DHA-E3 to over-come pgp mediated multidrug resistance, Biomedicine & Pharmacotherapy 84 (2016), 1610–1616.

25.

Alaye

Berger

S.M.

Kramer

M.Y.

et al., The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells, Journal of Cellular Biochemistry 116(3) (2015), 450–457.

26.

Zarzynska

J.M.

, The importance of autophagy regulation in breast cancer development and treatment, Biomed Research International (2014) (2014), 710345.

27.

Qiu

Liu

et al., Rhizoma amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway, J Ethnopharmacol (211) (2018), 89–100.

28.

Massihnia

Galvano

Fanale

et al., Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway, Oncotarget 7(37) (2016), 60712–60722.

29.

Misra

Ghatak

and Toole

B.P.

, Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide3-kinase, and ErbB2, Journal of Biological Chemistry 280(21) (2005), 20310–20315.

30.

A.W.

Hong

K.H.

Kim

H.S.

et al., Inorganic sulfur reduces cell proliferation by inhibiting of ErbB2 and ErbB3 protein and mRNA expression in MDA-MB-231 human breast cancer cells, Nutrition Research and Practice 7(2) (2013), 89–95.